235 related articles for article (PubMed ID: 21354147)
1. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.
Lu D; Han C; Wu T
Gastroenterology; 2011 Jun; 140(7):2084-94. PubMed ID: 21354147
[TBL] [Abstract][Full Text] [Related]
2. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.
Lu D; Han C; Wu T
Oncogene; 2012 Feb; 31(7):842-57. PubMed ID: 21743491
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in primary sclerosing cholangitis: ιmplications for cholangiocarcinogenesis.
Ishii Y; Sasaki T; Serikawa M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Shimizu A; Tsuboi T; Chayama K
Int J Oncol; 2013 Oct; 43(4):1073-9. PubMed ID: 23900502
[TBL] [Abstract][Full Text] [Related]
4. miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator.
Zhu H; Han C; Lu D; Wu T
Am J Pathol; 2014 Oct; 184(10):2828-39. PubMed ID: 25239565
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
[TBL] [Abstract][Full Text] [Related]
6. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
[TBL] [Abstract][Full Text] [Related]
7. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
Jongthawin J; Chusorn P; Techasen A; Loilome W; Boonmars T; Thanan R; Puapairoj A; Khuntikeo N; Tassaneeyakul W; Yongvanit P; Namwat N
Tumour Biol; 2014 Aug; 35(8):8051-64. PubMed ID: 24839005
[TBL] [Abstract][Full Text] [Related]
8. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.
Yao L; Han C; Song K; Zhang J; Lim K; Wu T
Cancer Res; 2015 Apr; 75(7):1388-98. PubMed ID: 25691459
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Zhu B; Wei Y
Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
[TBL] [Abstract][Full Text] [Related]
12. CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma.
Liao W; Du J; Li L; Wu X; Chen X; Feng Q; Xu L; Chen X; Liao M; Huang J; Yuan K; Zeng Y
J Exp Clin Cancer Res; 2023 May; 42(1):125. PubMed ID: 37198696
[TBL] [Abstract][Full Text] [Related]
13. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
[TBL] [Abstract][Full Text] [Related]
14. miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
Lu L; Byrnes K; Han C; Wang Y; Wu T
Mol Cancer Res; 2014 Jun; 12(6):890-900. PubMed ID: 24699315
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
16. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.
He Q; Cai L; Shuai L; Li D; Wang C; Liu Y; Li X; Li Z; Wang S
Mol Carcinog; 2013 Apr; 52(4):286-96. PubMed ID: 22213145
[TBL] [Abstract][Full Text] [Related]
17. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.
Kamei D; Murakami M; Nakatani Y; Ishikawa Y; Ishii T; Kudo I
J Biol Chem; 2003 May; 278(21):19396-405. PubMed ID: 12626523
[TBL] [Abstract][Full Text] [Related]
18. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
19. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
